🔴 SKIN is trading 5% down today after FDA clearance-driven surge

SKIN is trading 5% down at $1.05 in after-hours trading after a sharp regular-session rally triggered by FDA clearance for its wrinkle treatment system.

• The stock earlier soared 47% to $1.11 following news that the SkinStylus SteriLock MicroSystem received FDA clearance to treat periorbital wrinkles.
• This represents the third FDA-cleared indication for the system across all skin types, significantly boosting the company's long-term growth outlook.